4//SEC Filing
RALLIS CHRIS A 4
Accession 0001415889-24-024986
CIK 0001211583other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 5:14 PM ET
Size
8.9 KB
Accession
0001415889-24-024986
Insider Transaction Report
Form 4
RALLIS CHRIS A
Director
Transactions
- Exercise/Conversion
Common Shares
2024-10-08$2.55/sh−1,960$4,998→ 194,698 totalExercise: $2.55From: 2014-11-07Exp: 2024-11-07→ Options (1,960 underlying) - Exercise/Conversion
Common Shares
2024-10-08$2.55/sh+1,960$4,998→ 50,029 total - Sale
Common Shares
2024-10-08$4.53/sh−1,406$6,369→ 48,623 total
Footnotes (3)
- [F1]Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
- [F2]Shares sold to satisfy tax obligation on option exercise.
- [F3]Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001185945
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 5:14 PM ET
- Size
- 8.9 KB